Key Takeaways
- • RoC tripled global retail sales from approximately $100 million to $300 million between 2018 and 2024, while securing an estimated $500 million exit to new ownership under private equity stewardship.
- • The brand achieved 21 consecutive quarters of market share gains and reclaimed the No. 1 position in the U.S. eye cream category, according to NielsenIQ data, demonstrating sustained competitive recovery in a highly fragmented skincare market.
- • RoC more than doubled its EBITDA margins through disciplined operational focus rather than product line expansion or celebrity partnerships, highlighting the margin-accretive potential of brand repositioning within legacy beauty portfolios.
- • The transformation was grounded in brand equity preservation and leadership execution rather than aesthetic reinvention—the company intensified its existing dermatological positioning, originally established by founder Jean-Charles Lissarrague in 1957, rather than pursuing category disruption.
- • The case exemplifies private equity's capacity to unlock dormant brand value within larger conglomerates by providing aligned ownership, dedicated management infrastructure, and strategic sequencing focused on core category strength.
Summary
RoC's resurgence from 2018 to 2024 represents a textbook case of disciplined brand reactivation within the mass skincare category. Founded in 1957 by French pharmacist Jean-Charles Lissarrague, RoC had built foundational equity around dermatological rigor and stabilized retinol formulations long before clinical skincare became mainstream positioning. However, when housed within a larger healthcare conglomerate, the brand had become deprioritized despite retaining core credibility—a condition that changed under focused private equity ownership.
The financial transformation was substantial. Global retail sales tripled from roughly $100 million to approximately $300 million, while EBITDA margins more than doubled. The brand delivered 21 consecutive quarters of market share gains and achieved the No. 1 position in U.S. eye cream, a category leadership position documented by market research firm NielsenIQ. The ultimate liquidity event—an estimated $500 million exit—reflected the operational and commercial value creation achieved during the holding period.
What distinguishes RoC's case is its strategic methodology. Rather than pursuing aggressive line extensions, celebrity endorsements, or aesthetic reinvention, management executed a controlled, margin-accretive growth strategy centered on intensifying existing brand positioning. The transformation relied on three foundational elements: disciplined focus on core category strength, deliberate sequencing of operational and commercial initiatives, and construction of a leadership team aligned with execution capability. This approach preserved the brand's scientific credibility while rebuilding the operating infrastructure required to scale within its addressable market.
The outcome challenges the prevailing narrative around beauty brand transformation, which typically emphasizes disruption and line expansion. RoC instead demonstrates that reactivating dormant equity within a larger portfolio—particularly when combined with aligned ownership, dedicated management infrastructure, and focused resource allocation—can generate substantial returns without requiring the brand to abandon its foundational positioning. The case underscores private equity's continued relevance in the consumer discretionary space, particularly when applied to heritage brands with intact but underdeployed brand equity.
The financial transformation was substantial. Global retail sales tripled from roughly $100 million to approximately $300 million, while EBITDA margins more than doubled. The brand delivered 21 consecutive quarters of market share gains and achieved the No. 1 position in U.S. eye cream, a category leadership position documented by market research firm NielsenIQ. The ultimate liquidity event—an estimated $500 million exit—reflected the operational and commercial value creation achieved during the holding period.
What distinguishes RoC's case is its strategic methodology. Rather than pursuing aggressive line extensions, celebrity endorsements, or aesthetic reinvention, management executed a controlled, margin-accretive growth strategy centered on intensifying existing brand positioning. The transformation relied on three foundational elements: disciplined focus on core category strength, deliberate sequencing of operational and commercial initiatives, and construction of a leadership team aligned with execution capability. This approach preserved the brand's scientific credibility while rebuilding the operating infrastructure required to scale within its addressable market.
The outcome challenges the prevailing narrative around beauty brand transformation, which typically emphasizes disruption and line expansion. RoC instead demonstrates that reactivating dormant equity within a larger portfolio—particularly when combined with aligned ownership, dedicated management infrastructure, and focused resource allocation—can generate substantial returns without requiring the brand to abandon its foundational positioning. The case underscores private equity's continued relevance in the consumer discretionary space, particularly when applied to heritage brands with intact but underdeployed brand equity.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.